| 000 | 01888 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515111459.0 | ||
| 264 | 0 | _c20081231 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1476-5497 | ||
| 024 | 7 |
_a10.1038/ijo.2008.16 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPark, M | |
| 245 | 0 | 0 |
_aEnterostatin inhibition of angiogenesis: possible role of pAMPK and vascular endothelial growth factor A (VEGF-A). _h[electronic resource] |
| 260 |
_bInternational journal of obesity (2005) _cJun 2008 |
||
| 300 |
_a922-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenylate Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAminoimidazole Carboxamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aColipases _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Precursors _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xpathology |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 |
_aRibonucleotides _xpharmacology |
| 650 | 0 | 4 |
_aSubcutaneous Fat, Abdominal _xblood supply |
| 650 | 0 | 4 |
_aUmbilical Veins _xblood supply |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xgenetics |
| 700 | 1 | _aLyons, J | |
| 700 | 1 | _aOh, H | |
| 700 | 1 | _aYu, Y | |
| 700 | 1 | _aWoltering, E A | |
| 700 | 1 | _aGreenway, F | |
| 700 | 1 | _aYork, D A | |
| 773 | 0 |
_tInternational journal of obesity (2005) _gvol. 32 _gno. 6 _gp. 922-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ijo.2008.16 _zAvailable from publisher's website |
| 999 |
_c17804919 _d17804919 |
||